Andrew Kenneth William Powell - Nov 23, 2021 Form 4 Insider Report for Aclaris Therapeutics, Inc. (ACRS)

Role
Director
Signature
/s/ Mark Ballantyne, Attorney-in-fact
Stock symbol
ACRS
Transactions as of
Nov 23, 2021
Transactions value $
$0
Form type
4
Date filed
12/3/2021, 03:52 PM
Previous filing
Jun 8, 2021
Next filing
Jun 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACRS Common Stock Gift $0 -5.5K -32.92% $0.00 11.2K Nov 23, 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.